PureTech Health (NASDAQ:PRTC) Sees Strong Trading Volume

PureTech Health plc (NASDAQ:PRTC) saw strong trading volume on Thursday . 1,845 shares were traded during trading, a decline of 43% from the previous session’s volume of 3,251 shares.The stock last traded at $22.41 and had previously closed at $22.27.

PureTech Health Stock Down 1.1 %

The firm’s fifty day moving average is $25.56 and its two-hundred day moving average is $26.12.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in PureTech Health stock. Birch Hill Investment Advisors LLC acquired a new stake in shares of PureTech Health plc (NASDAQ:PRTC) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 302,000 shares of the company’s stock, valued at approximately $7,550,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health at the end of the most recent reporting period. 0.04% of the stock is owned by institutional investors and hedge funds.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.